Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17,255,853
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
12,252,400
-
Shares change
-
-1,114,338
-
Total reported value, excl. options
-
$59,913,404
-
Value change
-
-$6,550,206
-
Number of buys
-
28
-
Number of sells
-
85
-
Price
-
$4.89
Institutional Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q1 2024
As of 31 Mar 2024 Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) had 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,252,400 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, BlackRock Inc., VANGUARD GROUP INC, Verition Fund Management LLC, Solas Capital Management, LLC, Alta Fundamental Advisers LLC, Newtyn Management, LLC, Prosight Management, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 94 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.